ESMO 2022: DDR In Detail Infographic

There were nearly 2000 abstracts presented at the ESMO Congress 2022 by a vast array of developers, of which 44 were relevant to the DNA Damage Response (DDR) field. Here, we will discuss the significance of the data presented and contextualize the findings against the broader DDR landscape to date. Despite the continuing dominance of assets targeting PARP, we are seeing a dramatic increase in developers formulating drugs to act on other DDR-relevant targets such as ATR.